Cargando…

Re-emergence of TIVA in COVID times

Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia (GA) given via intravenous route exclusively. In perspective of COVID-19, TIVA is far more advantageous than inhalational anaesthesia. It avoids the deleterious effects of immunosuppression and lacks any respiratory irritatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokshi, Tushar, Channabasappa, Shivakumar, Vergheese, Davies C, Bajwa, Sukhminder Jit Singh, Gupta, Bhavna, Mehdiratta, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293370/
https://www.ncbi.nlm.nih.gov/pubmed/32773851
http://dx.doi.org/10.4103/ija.IJA_554_20
_version_ 1783546289719345152
author Chokshi, Tushar
Channabasappa, Shivakumar
Vergheese, Davies C
Bajwa, Sukhminder Jit Singh
Gupta, Bhavna
Mehdiratta, Lalit
author_facet Chokshi, Tushar
Channabasappa, Shivakumar
Vergheese, Davies C
Bajwa, Sukhminder Jit Singh
Gupta, Bhavna
Mehdiratta, Lalit
author_sort Chokshi, Tushar
collection PubMed
description Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia (GA) given via intravenous route exclusively. In perspective of COVID-19, TIVA is far more advantageous than inhalational anaesthesia. It avoids the deleterious effects of immunosuppression and lacks any respiratory irritation, thus providing an edge in the current situation. Many peripheral surgeries can be done with the patient breathing spontaneously without any airway device, thus avoiding airway instrumentation leading to droplet and aerosol generation. Intravenous agents can be utilized to provide sedation during regional anaesthesia (RA), which can easily be escalated to contain pain due to sparing of blocks or receding neuraxial anaesthesia. The present narrative review focuses on the merits of adopting TIVA technique during this pandemic so as to decrease the risk and morbidity arising from anaesthetizing COVID-19 patients.
format Online
Article
Text
id pubmed-7293370
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-72933702020-08-07 Re-emergence of TIVA in COVID times Chokshi, Tushar Channabasappa, Shivakumar Vergheese, Davies C Bajwa, Sukhminder Jit Singh Gupta, Bhavna Mehdiratta, Lalit Indian J Anaesth Special Article Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia (GA) given via intravenous route exclusively. In perspective of COVID-19, TIVA is far more advantageous than inhalational anaesthesia. It avoids the deleterious effects of immunosuppression and lacks any respiratory irritation, thus providing an edge in the current situation. Many peripheral surgeries can be done with the patient breathing spontaneously without any airway device, thus avoiding airway instrumentation leading to droplet and aerosol generation. Intravenous agents can be utilized to provide sedation during regional anaesthesia (RA), which can easily be escalated to contain pain due to sparing of blocks or receding neuraxial anaesthesia. The present narrative review focuses on the merits of adopting TIVA technique during this pandemic so as to decrease the risk and morbidity arising from anaesthetizing COVID-19 patients. Wolters Kluwer - Medknow 2020-05 2020-05-23 /pmc/articles/PMC7293370/ /pubmed/32773851 http://dx.doi.org/10.4103/ija.IJA_554_20 Text en Copyright: © 2020 Indian Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Special Article
Chokshi, Tushar
Channabasappa, Shivakumar
Vergheese, Davies C
Bajwa, Sukhminder Jit Singh
Gupta, Bhavna
Mehdiratta, Lalit
Re-emergence of TIVA in COVID times
title Re-emergence of TIVA in COVID times
title_full Re-emergence of TIVA in COVID times
title_fullStr Re-emergence of TIVA in COVID times
title_full_unstemmed Re-emergence of TIVA in COVID times
title_short Re-emergence of TIVA in COVID times
title_sort re-emergence of tiva in covid times
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293370/
https://www.ncbi.nlm.nih.gov/pubmed/32773851
http://dx.doi.org/10.4103/ija.IJA_554_20
work_keys_str_mv AT chokshitushar reemergenceoftivaincovidtimes
AT channabasappashivakumar reemergenceoftivaincovidtimes
AT vergheesedaviesc reemergenceoftivaincovidtimes
AT bajwasukhminderjitsingh reemergenceoftivaincovidtimes
AT guptabhavna reemergenceoftivaincovidtimes
AT mehdirattalalit reemergenceoftivaincovidtimes